Cyprus vs Eritrea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cyprus
0.5%
in 2024
Eritrea
0.5%
in 2024
Cyprus rank
56th
Eritrea rank
56th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cyprus
- Eritrea
How they compare
Cyprus currently reports 0.5% against 0.5% in Eritrea, a difference of 0.0%.
Across all 10 years both countries report, Eritrea has been ahead every year.
Cyprus ranks 56th and Eritrea ranks 56th of 215 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.0% | Eritrea |
| 2020s | 0.5% | 0.6% | 0.1% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cyprus or Eritrea?
- Cyprus, at 0.5% against 0.5% in Eritrea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cyprus and Eritrea?
- 0.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Eritrea?
- 10 years are reported by both, from 2015 to 2024.
- How do Cyprus and Eritrea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cyprus ranks 56th and Eritrea ranks 56th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.